Osterweis Capital Management Inc Novartis Ag Transaction History

Osterweis Capital Management Inc

  • $1.67 Billion
  • Q3 2024

A detailed history of Osterweis Capital Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Osterweis Capital Management Inc holds 81,910 shares of NVS stock, worth $8.06 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
81,910
Previous 81,189 0.89%
Holding current value
$8.06 Million
Previous $8.64 Million 9.0%
% of portfolio
0.56%
Previous 0.56%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$106.13 - $120.89 $76,519 - $87,161
721 Added 0.89%
81,910 $9.42 Million
Q2 2024

Aug 14, 2024
BUY
$92.57 - $107.37 $226,333 - $262,519
2,445 Added 3.1%
81,189 $8.64 Million
Q1 2024

May 15, 2024
SELL
$95.27 - $108.47 $104,415 - $118,883
-1,096 Reduced 1.37%
78,744 $7.62 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $707,618 - $778,710
7,669 Added 10.63%
79,840 $8.06 Million
Q3 2023

Nov 14, 2023
BUY
$94.73 - $105.13 $10,420 - $11,564
110 Added 0.15%
72,171 $7.35 Million
Q2 2023

Aug 14, 2023
BUY
$92.52 - $104.91 $886,619 - $1.01 Million
9,583 Added 15.34%
72,061 $7.27 Million
Q1 2023

May 15, 2023
BUY
$80.03 - $92.81 $132,449 - $153,600
1,655 Added 2.72%
62,478 $5.75 Million
Q4 2022

Feb 14, 2023
BUY
$75.55 - $92.52 $68,146 - $83,453
902 Added 1.51%
60,823 $5.52 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $33,947 - $39,703
-455 Reduced 0.75%
59,921 $4.56 Million
Q2 2022

Aug 15, 2022
BUY
$80.52 - $93.75 $1,771 - $2,062
22 Added 0.04%
60,376 $5.1 Million
Q1 2022

May 16, 2022
SELL
$80.11 - $90.62 $17,784 - $20,117
-222 Reduced 0.37%
60,354 $5.3 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $1.47 Million - $1.63 Million
-18,491 Reduced 23.39%
60,576 $5.3 Million
Q3 2021

Nov 15, 2021
SELL
$81.78 - $95.14 $15.9 Million - $18.6 Million
-194,998 Reduced 71.15%
79,067 $6.47 Million
Q2 2021

Aug 16, 2021
SELL
$85.24 - $94.15 $846,433 - $934,909
-9,930 Reduced 3.5%
274,065 $25 Million
Q1 2021

May 14, 2021
BUY
$83.5 - $98.47 $2,087 - $2,461
25 Added 0.01%
283,995 $24.3 Million
Q4 2020

Feb 12, 2021
BUY
$78.07 - $94.43 $3.85 Million - $4.66 Million
49,365 Added 21.04%
283,970 $26.8 Million
Q3 2020

Nov 13, 2020
SELL
$82.14 - $91.0 $3.19 Million - $3.53 Million
-38,794 Reduced 14.19%
234,605 $20.4 Million
Q2 2020

Aug 14, 2020
SELL
$80.93 - $91.1 $1.4 Million - $1.58 Million
-17,325 Reduced 5.96%
273,399 $23.9 Million
Q1 2020

May 15, 2020
SELL
$70.67 - $99.01 $771,363 - $1.08 Million
-10,915 Reduced 3.62%
290,724 $24 Million
Q4 2019

Feb 14, 2020
SELL
$84.35 - $95.37 $157,397 - $177,960
-1,866 Reduced 0.61%
301,639 $28.6 Million
Q3 2019

Nov 14, 2019
SELL
$85.54 - $94.26 $234,379 - $258,272
-2,740 Reduced 0.89%
303,505 $26.4 Million
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $95,908 - $118,041
1,272 Added 0.42%
306,245 $28 Million
Q1 2019

May 15, 2019
SELL
$75.32 - $86.15 $5.05 Million - $5.78 Million
-67,100 Reduced 18.03%
304,973 $29.3 Million
Q4 2018

Feb 14, 2019
SELL
$73.66 - $82.02 $1.79 Million - $2 Million
-24,365 Reduced 6.15%
372,073 $31.9 Million
Q3 2018

Nov 13, 2018
SELL
$66.94 - $77.43 $6.98 Million - $8.08 Million
-104,340 Reduced 20.84%
396,438 $34.2 Million
Q2 2018

Aug 13, 2018
SELL
$64.91 - $73.36 $1.03 Million - $1.16 Million
-15,860 Reduced 3.07%
500,778 $37.8 Million
Q1 2018

May 14, 2018
SELL
$70.39 - $84.15 $1.87 Million - $2.24 Million
-26,570 Reduced 4.89%
516,638 $41.8 Million
Q4 2017

Feb 14, 2018
BUY
$72.33 - $77.64 $776,824 - $833,853
10,740 Added 2.02%
543,208 $45.6 Million
Q3 2017

Nov 13, 2017
BUY
$74.14 - $77.27 $39.5 Million - $41.1 Million
532,468
532,468 $45.7 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Osterweis Capital Management Inc Portfolio

Follow Osterweis Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Osterweis Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Osterweis Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email